YUHSpace: 1. Journal Papers
menu
About
Yonsei University Medical Library
검색
All
Title
Author
Keyword / MeSH
Year
Journal Title
Contains
Equals
YUHASpace Repository
YUHSpace
About YUHSpace
Guildeline
BROWSE
Colleges & Departments
Yonsei Authors
Titles
Journal Titles
Publication Year
YUHS Publication
(연세의료원 간행물)
YUHSpace
1. College of Medicine (의과대학)
Dept. of Internal Medicine (내과학교실)
1. Journal Papers
search for
or browse
Issue Date
Author
Title
Other Title
Identifier
Subscribe to this collection to receive daily e-mail notification of new additions
This table browses all dspace content
Issue Date
Title
Journal Title
2022
Exploratory biomarker analysis from neoadjuvant atezolizumab, pertuzumab, trastuzumab plus docetaxel (NEO-PATH) in HER2+ early breast cancer
ANNALS OF ONCOLOGY
2022
Exploratory analysis of the impact of prior immune checkpoint inhibitor (ICI) on trastuzumab deruxtecan (T-DXd; DS-8201) clinical outcomes and biomarkers (BM) in DESTINY-Gastric01 (DG-01), a randomized, phase 2, multicenter, open-label study in patients (pts) with HER2+ advanced gastric or gastroesophageal junction adenocarcinoma
JOURNAL OF CLINICAL ONCOLOGY
2022
Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2022
Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-Up Outcomes of Multicenter Randomized Controlled BEST Trial
CIRCULATION
2022
ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib
ANNALS OF ONCOLOGY
2022
Elacestrant vs fulvestrant or aromatase inhibitor (AI) in phase III trial evaluating elacestrant, an oral selective estrogen receptor degrader (SERD), vs standard of care (SOC) endocrine monotherapy for ER+/HER2- advanced/metastatic breast cancer (mBC): Subgroup analysis from EMERALD
ANNALS OF ONCOLOGY
2022
Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure Targets
KOREAN CIRCULATION JOURNAL
2022
Efficient gene transfection to lung cancer cells via Folate-PEI-Sorbitol gene transporter
PLOS ONE
2022
Efficacy of Endoscopic and Surgical Treatments for Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-Analysis
JOURNAL OF PERSONALIZED MEDICINE
2022
Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry
RHEUMATOLOGY AND THERAPY
2022
Efficacy and safety of pembrolizumab (pembro) monotherapy in East Asian patients (pts) with urothelial carcinoma (UC) in KEYNOTE-045 or KEYNOTE-052
ANNALS OF ONCOLOGY
2022
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial
JOURNAL OF CLINICAL HYPERTENSION
2022
Efficacy and safety of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in the East Asian subset of patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial
JOURNAL OF CLINICAL ONCOLOGY
2022
Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial
CLINICAL JOURNAL OF PAIN
2022
Effects of screening and treatment improvement on colon cancer survival over 20 years in Korea
ANNALS OF ONCOLOGY
2022
Effects of mango and mint pod-based e-cigarette aerosol inhalation on inflammatory states of the brain, lung, heart, and colon in mice
ELIFE
2022
Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT
2022
Effect of Stenting Strategy on the Outcome in Patients with Non-Left Main Bifurcation Lesions
JOURNAL OF CLINICAL MEDICINE
2022
Early experience of combining immune checkpoint inhibitor and radiotherapy in heavily pretreated hepatobiliary cancer
JOURNAL OF CLINICAL ONCOLOGY
2022
Durvalumab + chemotherapy in patients (pts) with advanced EGFR mutation-positive (EGFRm) NSCLC whose disease progressed on first-line (1L) osimertinib: An ORCHARD study interim analysis
ANNALS OF ONCOLOGY
1
60
61
62
63
64
65
66
67
68
69
70
71
691
Recent Submissions
Browse
Communities & Collections
Titles
Yonsei Authors
Journal Titles
By date
Links
About
Yonsei University Medical Library